Deciphera Pharmaceuticals DCPH
$ 25.59
0.0%
Annual report 2023
added 02-07-2024
Country |
USA |
IPO year |
2017 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBALSPB |
CEO |
Mr. Steven Hoerter |
Employees in the company |
255 |
Shares |
85.1 M |
Market Cap[1] |
$ 2.18 B |
EBITDA (LTM) |
$ -185 M |
P/E (LTM) |
-5.19 |
P/S (LTM) |
5.96 |
EPS (LTM) |
-2.3 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.